Document is current
Any future updates will be listed below
-
Authors
Fokkink, Willem Jan R.
van Tilburg, Sander J.
de Winter, Brenda C. M.
Sassen, Sebastiaan D. T.
van Doorn, Pieter A.
Koch, Birgit C. P.
Jacobs, Bart C. https://orcid.org/0000-0002-8985-2458
-
Funding
Funding for this research was provided by:
Prinses Beatrix Spierfonds (W.OR11-27, W.OR19-24)
- License Information
-
More Information
Article History
Accepted: 2 May 2022
First Online: 4 July 2022
Declarations
:
: This work has been supported by an unconditional research grant from the Prinses Beatrix Spierfonds (Grant W.OR11-27 and W.OR19-24).
: P.A.D. received honoraria and/or unrestricted research support from the Prinses Beatrix Spierfonds, Janivo Stichting, Baxalta, Grifols, Shire, Hans Biopharma, Kedrion, Octapharma and Sanquin Plasma Pharmaceuticals. B.C.J. received unrestricted research support from the Netherlands Organization for Health Research and Development, Erasmus MC, Prinses Beatrix Spierfonds, GBS-CIDP Foundation International, Baxalta, CSL-Behring, Grifols, Annexon and Hansa Biopharma. The other authors have no conflicts of interest that are directly relevant to the contents of this study.
: This retrospective study was exempted from the Medical Research Involving Human Subjects Act (Dutch law, WMO) by the Institutional Review Board of Erasmus University Medical Center Rotterdam (reference number: MEC-2016-173).
: Not applicable.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: The final NONMEM model code is provided in the Electronic Supplementary Material.
: WJRF, SJT, BCMW, BCPK, PAD and BCJ wrote the manuscript; WJRF, BCPK and BCJ designed the research; WJRF, SJT, BCMW and BCPK performed the research; and WJRF, SJT, BCMW and BCPK analysed the data.
